Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyneuropathy, Inflammatory Demyelinating, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06620198
What this trial is testing

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome

Who this might be right for
Guillain Barré Syndrome
I.R.C.C.S. Fondazione Santa Lucia 62
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 100
Not applicableUnknownNCT01655394
What this trial is testing

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

Who this might be right for
Guillain-Barre SyndromeCIDPMultifocal Motor Neuropathy
University of Cologne 50
Not applicableUnknownNCT03801135
What this trial is testing

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Who this might be right for
Humoral RejectionGuillain-Barre SyndromeMiller Fisher Syndrome+3 more
University Medical Centre Ljubljana 20
Not applicableLooking for participantsNCT07154524
What this trial is testing

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
University of Ulm 140
Post-approval studies (Phase 4)UnknownNCT02372149
What this trial is testing

IVIg for Demyelination in Diabetes Mellitus

Who this might be right for
Peripheral NeuropathyDiabetes MellitusChronic Inflammatory Demyelinating Polyneuropathy
University of Toronto 25
Not applicableNo Longer AvailableNCT04825626
What this trial is testing

An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Hope Biosciences Research Foundation
Large-scale testing (Phase 3)Not Yet RecruitingNCT06858722
What this trial is testing

Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Zhongming Qiu 175
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Testing effectiveness (Phase 2)WithdrawnNCT02574962
What this trial is testing

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Mamatha Pasnoor, MD
Large-scale testing (Phase 3)Looking for participantsNCT06747351
What this trial is testing

Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda 59
Not applicableUnknownNCT05940922
What this trial is testing

RWE-based Treatment Patterns and Outcomes in CIDP

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
RwHealth 170
Testing effectiveness (Phase 2)WithdrawnNCT01236456
What this trial is testing

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University
Post-approval studies (Phase 4)WithdrawnNCT01757574
What this trial is testing

Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)

Who this might be right for
Chronic Inflammatory Demyelinating Neuropathy
Johns Hopkins University
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Not applicableStudy completedNCT01379833
What this trial is testing

Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
State University of New York at Buffalo 18
Large-scale testing (Phase 3)Study completedNCT01184846
What this trial is testing

Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
CSL Behring 31
Not applicableStudy completedNCT03008733
What this trial is testing

Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Centre Hospitalier Universitaire de Nice 36
Testing effectiveness (Phase 2)Looking for participantsNCT04881682
What this trial is testing

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
CIDP
University of Ulm 20
Large-scale testing (Phase 3)Study completedNCT02027701
What this trial is testing

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
CSL Behring 82
Next Page